Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

An announcement made by the Swiss drugmaker Novartis AG (NVS: Quote) on Wednesday suggested about the late-breaking results omalizumab clearing all the primary and secondary endpoints of a pivotal Phase III safety registration study in chronic spontaneous urticaria or CSU.

It is a chronic and debilitating form of hives with partial approved treatment options. GLACIAL is considered as the second of three pivotal Phase III studies. These studies conduct analysis about the efficacy and safety of omalizumab in CSU.

The result derived from the study supported supported the efficacy, safety and tolerability of omalizumab in patients with refractory CSU. It is a kind of chronic and debilitating skin disease with obstinate itch and hives.

Near about 40 percent of CSU patients were unsuccessful on ntihistamines. These include those who were taking the approved dose even for the fourth time. The doses, in terms of official regulations are currently available only for treatment for CSU.

However, Omalizumab is presently not at all approved or indicated for CSU. Supervision of the submissions for omalizumab in CSU is scheduled for later times in the current year. It is a collaborated effort of Novartis and Genentech, Inc.

The data was brought forward for the first time at the European Academy of Allergy and Clinical Immunology-World Allergy Organization World Allergy and Asthma Congress 2013 in Milan which is located in Italy.


FrenchTribune Specials

Mediterranean diet reduces risk of womb cancer, study

According to a new study, adapting a Mediterranean diet can significantly reduce to risk of getting womb cancer.The researchers found that those who followed a Mediterranean diet have lowered their risk of womb cancer by 57 per cent.

They said that women who have Mediterranean diet can halve the risk of getting womb cancer. The disease...

Most Popular

EMC attempting to acquire Virtustream

In a bid to broaden its scope of cloud management tools...

Biologists perplexed at existence of 11 disparate species of Panther chameleons

An extensive study into the reasons for color variation...

Scientists convert embryonic stem cells into inner-ear hair cells

A new research published in the journal Development...

Researchers discover a gene that can make human brain sensitive to pain

Reporting a momentous new discovery, an international...

Poll

Can Greece Come out of Economic Problems: